Rendu Biotech Successfully Listed on the STAR Market | Chenkun Family

2022-03-30

On March 30, 2022, "Rendu Bio," an investee company of Qiming Venture Partners—a sub-fund backed by the mother fund managed by Yuanhe Chukun—officially listed on the STAR Market of the Shanghai Stock Exchange, with stock code: 688193.

Xingtong Shares Listed on the Shanghai Stock Exchange Main Board | Chenkun Family

2022-03-24

On March 24, 2022, Xingtong Shares, an investee company of Zhongding Capital—a sub-fund backed by the mother fund managed by Yuanhe Chukun—was listed on the Shanghai Stock Exchange under stock code 603209.

Silingjie Officially Listed on the STAR Market of the Shanghai Stock Exchange | Chenkun Family

2022-03-14

On March 14, 2022, "Silinjie," an investee company backed by the sub-funds—Fangguang Capital and Qiancheng Capital—of the mother fund managed by Yuanhe Chencun, officially listed on the STAR Market of the Shanghai Stock Exchange, with stock code: 688115.

Huitongda Officially Lists on the Hong Kong Stock Exchange | Chenkun Family

2022-02-18

On February 18, 2022, "Huitongda," a portfolio company invested in by the sub-fund backed by the mother fund managed by Yuanhe Chenchun Capital, successfully listed on the Hong Kong Stock Exchange under the stock code: 9878.HK.

Hualan Vaccine Successfully Listed on Shenzhen Stock Exchange's ChiNext Board | Chenkun Family

2022-02-18

On February 18, 2022, "Hualan Vaccine," a company directly invested in by Yuanhe BingSheng Fund—managed by Yuanhe Chencun—successfully listed on the ChiNext Board, with stock code: 301207.

SenseTime Successfully Listed on HKEX | Chenkun Family

2021-12-30

On December 30, 2021, "SenseTime," a portfolio company directly invested in by Yuanhe BingSheng Fund—managed by Yuanhe Chukun—successfully listed on the Hong Kong Stock Exchange under the stock code 0020.HK.